Why the study?
Do ETB receptor selective agonists (ET-3 and SS6c) affect renal function and blood pressure in spontaneously hypertensive rats?
Do ETB receptor selective agonists (ET-3 and SS6c) affect renal function and blood pressure in spontaneously hypertensive rats?
ETB receptor selective agonists ET-3 and SS6c markedly decrease GFR and RPF in spontaneously hypertensive rats, suggesting endogenous ET-3 modulates renal function via ETB receptors.
Answers are grounded in this paper and cite their sources.
ETB agonism impairs renal hemodynamics in hypertensive rats; leaves open therapeutic implications for human disease.
Renal effects of endothelin (ET)-3 have been described in normotensive but not spontaneously hypertensive rats (SHR). Infusion (170 ng/kg/min) of the ETB receptor selective agonists ET-3 and sarafotoxin S6c (SS6c) was used to investigate ETB receptor modulation of renal function in SHR. ET-3 decreased glomerular filtration rate (GFR) and renal plasma flow (RPF) by approximately 95% (0.1 +/- 0.01 and 0.1 +/- 0.02 ml/min, respectively) versus vehicle (1.3 +/- 0.08 and 3.6 +/- 0.23, respectively) in SHR. ET-3 exerted a biphasic effect on urine flow (UV); an initial increase and then a decrease (vehicle, 4.2 +/- 0.55; ET-3, 0.2 +/- 0.09 microliter/min). ET-3 increased mean arterial pressure (vehicle, 159 +/- 4.1; ET-3, 174 +/- 3.1 mm Hg). SS6c decreased GFR and RPF by approximately 60% (0.8 +/- 0.12 and 2.0 +/- 0.18 ml/min, respectively) versus vehicle (2.0 +/- 0.19 and 5.2 +/- 0.45, respectively). UV did not change. Depressor effects of SS6c were observed (vehicle, 154 +/- 1.5; SS6c, 127 +/- 3.1 mm Hg). The ETB receptor selective agonists ET-3 and SS6c markedly decreased GFR and RPF in SHR, suggesting that endogenous ET-3 may modulate renal function through ETB receptors in SHR.
No takes yet. Share an insight, caveat, or question.
Bird et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: